Additionally, patients with atrial fibrillation/flutter (AF/AFL) are predisposed to higher risks of thrombo-embolic events. To evaluate the risks of thromboembolism following COVID-19 vaccination ...

DOYLESTOWN, PA — Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary ...

Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...

Bisphosphonates are an effective treatment for osteoporosis, but several trials reported an association between use of these drugs and an increased risk of atrial fibrillation and flutter ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

On Sunday morning, the Norwegian Royal House announced that Queen Sonja of Norway regained a normal heart rhythm and was ...

Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...